Halofenate - CISMeF

Preferred Label : Halofenate;

NCIt definition : A selective peroxisome proliferator-activated receptor gamma (PPAR-gamma) modulator with antilipidemic activity. Halofenate also decreases fasting plasma glucose in type 2 diabetic patients, but not normoglycemic subjects.;

UNII : K9TZK4MNO6;

InChIKey : BJBCSGQLZQGGIQ-UHFFFAOYSA-N;

CAS number : 26718-25-2;

Molecule name : MK-185;

Chemical formula : C19H17ClF3NO4;

PubMed : 5010680;

Details

Origin ID

C83805;

UMLS CUI

C0018541;

Automatic exact mappings (from CISMeF team)
- Halofenate [ICHI extension code]
Currated CISMeF NLP mapping
- Halofenate [ICD-11 Extension code]
- halofenate [MeSH Descriptor]
- halofenate [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Halofenate [ICD-11 Extension code]
- halofenate [MeSH concept]
- halofenate [MeSH Descriptor]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients